| Identification | Back Directory | [Name]
DOTA Zoledronate | [CAS]
1908409-18-6 | [Synonyms]
DOTA Zoledronate
Gadobutrol Impurity 76
1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid, 10-[2-[[2-[1-(2-hydroxy-2,2-diphosphonoethyl)-1H-imidazol-4-yl]ethyl]amino]-2-oxoethyl]- | [Molecular Formula]
C23H41N7O14P2 | [MOL File]
1908409-18-6.mol | [Molecular Weight]
701.56 |
| Chemical Properties | Back Directory | [density ]
1.68±0.1 g/cm3(Predicted) | [solubility ]
Methanol (Slightly), Water (Slightly) | [form ]
Solid | [pka]
1.41±0.10(Predicted) | [color ]
White to Off-White | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
DOTA Zoledronate is a reactant used in the therapy of bone diseases interacting with metal isotopes and undergoing chelation. |
|
|